Menu

Breast tenderness references


Search over 8,400 pages on this site...

Journal of Endocrinology (2010) 206, 1-11
New concepts in prolactin biology

Journal of Endocrinology (2009) 203, 99-110
Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes

Environmental Health Perspectives Volume 116, Number 5, May 2008
Diet and Nutrition: Eye on Iodine

Clin Endocrinol (Oxf). 2008 May;68(5):806-13
Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress

Altern Med Rev. 2008 Jun;13(2):116-27
Iodine: deficiency and therapeutic considerations

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2029-35
Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women

Evid Based Complement Alternat Med. 2008 September; 5(3): 247250
Can Vitex Agnus Castus be Used for the Treatment of Mastalgia? What is the Current Evidence?

Clinical Cancer Research November 2005 11; 8036
Positive Correlation between Estradiol and Vascular Endothelial Growth Factor but not Fibroblast Growth Factor-2 in Normal Human Breast Tissue In vivo

Lupus September 2004 vol. 13 no. 9 635-638
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity

The Journal of Clinical Endocrinology & Metabolism 2003, Vol. 88, No. 2 689-696
Prolactin Expression and Secretion by Human Breast Glandular and Adipose Tissue Explants

CANCER CAUSES AND CONTROL 2000, Volume 11, Number 2, 121-127
Hypothesis: Iodine, selenium and the development of breast cancer

The Journal of Biological Chemistry May 5, 2000, 275, 13183-13186
Proteolytic Cleavage Confers Nitric Oxide Synthase Inducing Activity upon Prolactin

BREAST CANCER RESEARCH AND TREATMENT 1999, Volume 53, Number 3, 217-227
Pattern of distribution of cells positive for estrogen receptor and progesterone receptor in relation to proliferating cells in the mammary gland

J R Soc Med 1998;91:462-464
The long-term course of mastalgia

American Journal of Clinical Nutrition, 1998, Vol 68, 1431S-1435S
Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast

Fertility and Sterility Volume 69, Issue 5, Pages 963-969 (May 1998)
Estradiol and Progesterone Regulate the Proliferation of Human Breast Epithelial Cells

BREAST CANCER RESEARCH AND TREATMENT 1997, Volume 45, Number 2, 121-133
Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: Analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression

Minerva Med. 1997 Nov;88(11):479-87
Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment

Endocrinology, 1995, Vol 136, 164-171
The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone

Obstet Gynecol Clin North Am. 1994 Sep;21(3):461-77
Mastodynia

Can J Surg. 1993 Oct;36(5):453-60
Iodine replacement in fibrocystic disease of the breast

J Endocrinol Invest. 1992 Dec;15(11):801-6
Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease

Journal of Neuroendocrinology, 1990, Vol. 2, No. 3
Dose-Related Effects of Progesterone and 5 Alpha-Di hydroprogesterone upon Estrogen-Induced Prolactin Release

Journal of Endocrinology (1989) 120, 37-43
Feedback regulation by progesterone of stress-induced prolactin release in rats

Clin Exp Obstet Gynecol. 1981;8(4):160-3
Inadequate luteal phase and benign breast disease

Can Med Assoc J. 1981 Feb 1;124(3):283-91
Risk factors for benign breast disease: a 30-year cohort study

Arch Pathol Lab Med. 1979 Nov;103(12):631-4
Age-related changes resembling fibrocystic disease in iodine-blocked rat breasts

Obstet Gynecol. 1979 Apr;53(4):457-60
Benign breast disease I: hormonal investigation

AJR Am J Roentgenol. 1978 Sep;131(3):459-64
Computed tomographic evaluation of the breast

J Clin Endocrinol Metab. 1977 Apr;44(4):771-4
Inadequate corpus luteal function in women with benign breast diseases

Nature 266 , 641 - 643 (14 April 1977)
Prolactin - progesterone antagonism in self regulation of prolactin receptors in the mammary gland

J Gynecol Obstet Biol Reprod (Paris). 1975;4(7):965-70
Hormonal function of the ovarian corpus luteum during benign mammary diseases

Nature 255, 497 - 498 (05 June 1975)
Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells

The American Journal of Surgery Volume 106, Issue 3, September 1963, Pages 382-395
The treatment of mammary dysplasia with special reference to microcystic and macrocystic disease of the breast


Return to home page

Share this page:
Find this page helpful? Please tell others. Here's how...

Would you prefer to share this page with others by linking to it?

  1. Click on the HTML link code below.
  2. Copy and paste it, adding a note of your own, into your blog, a Web page, forums, a blog comment, your Facebook account, or anywhere that someone would find this page valuable.

Search over 8,400 pages on this site...